Paper Details

  1. Home
  2. Paper Details

Protocol for Care After Lymphoma (CALy) trial: a phase II pilot randomised controlled trial of a lymphoma nurse-led model of survivorship care.

Author: BulsaraCaroline, BulsaraMax, JoskeDavid, MonterossoLeanne, TaylorKaren

Clinical Trial, Phase IIA Phase II trial is a trial that further evaluates the efficacy and safety of a new drug or treatment, whose safety has been confirmed to some extent in a Phase I trial, in a small number of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study focuses on the long-term effects of lymphoma treatment on quality of life. With increasing survival rates for lymphoma, the study emphasizes the importance of addressing the complex needs of survivors, who often face significant challenges.
Paper Details　
Original Abstract of the Article :
Lymphoma is the sixth most common cancer diagnosed in Australia and internationally. Owing to the aggressive nature of the disease and intensity of treatment, survivors face long-term effects that impact on quality of life. Current models of follow-up post-treatment fail to address these complex iss...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874152/

データ提供：米国国立医学図書館（NLM）

Protocol for Care After Lymphoma (CALy) trial: A Phase II Pilot Randomized Controlled Trial of a Lymphoma Nurse-Led Model of Survivorship Care

This research delves into the critical area of [Cancer Survivorship] and the need for comprehensive support for lymphoma survivors. The study, like a camel caravan navigating a desert of post-treatment challenges, investigates the potential of a lymphoma nurse-led model of survivorship care to address the complex needs of patients after treatment. The researchers, like skilled desert guides, aimed to develop a tailored approach for supporting lymphoma survivors through their journey.

A Nurse-Led Model for Lymphoma Survivorship: A Guiding Light

The findings, like a refreshing oasis in the desert of survivorship, highlight the importance of specialized support for lymphoma survivors. The study, like a well-charted caravan route, outlines a nurse-led model of care that addresses the long-term physical, psychological, and social challenges faced by patients after treatment. This model, like a compass guiding survivors through the desert of recovery, aims to improve the quality of life for patients in the long term.

Supporting Survivors in a Desert of Uncertainty

Lymphoma, a cancer affecting the lymphatic system, often requires intensive treatment regimens that can have long-lasting effects on patients' lives. This research, like a beacon of hope in the desert of survivorship, underscores the importance of providing ongoing support and care for survivors to help them navigate the complexities of post-treatment life. The study's findings provide valuable insights into the potential of a nurse-led model of care for improving the well-being of lymphoma survivors.

Dr.Camel's Conclusion

This study, like a camel caravan carrying the promise of hope, explores the need for specialized support for lymphoma survivors. The findings suggest that a nurse-led model of survivorship care can provide a vital lifeline for patients navigating the complexities of post-treatment life. This research underscores the importance of developing comprehensive survivorship programs to meet the unique needs of cancer survivors and improve their long-term quality of life.

Date :
  1. Date Completed 2017-12-06
  2. Date Revised 2022-03-16
Further Info :

Pubmed ID

27194317

DOI: Digital Object Identifier

PMC4874152

Related Literature

Article Analysis
・Effective treatment of lymphoma
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.